<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: <z:e sem="disease" ids="C0272170" disease_type="Disease or Syndrome" abbrv="">Shwachman-Diamond syndrome</z:e> (<z:chebi fb="26" ids="8984">SDS</z:chebi>) is a rare inherited disorder characterized by <z:e sem="disease" ids="C0030293" disease_type="Disease or Syndrome" abbrv="">pancreatic insufficiency</z:e>, <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, and in some patients, <z:hpo ids='HP_0005899'>metaphyseal dysostosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with <z:chebi fb="26" ids="8984">SDS</z:chebi> are at a high risk for development of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The p53 gene plays a major role in cell-cycle regulation, particularly in the presence of a genetic alteration in DNA, a critical step for the initiation of <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>p53 gene up-regulation and p53 protein overexpression may occur as a cellular reaction to significant DNA damage </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0272170" disease_type="Disease or Syndrome" abbrv="">Shwachman-Diamond syndrome</z:e> and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> patients have close similarities in the prevalence of <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and in cell-cycle changes in bone marrow cells </plain></SENT>
<SENT sid="5" pm="."><plain>This similarity was further investigated for p53 protein overexpression using archived tissue from patients with <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e> having various leukemic propensities, including <z:chebi fb="26" ids="8984">SDS</z:chebi> and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>METHODS: Immunohistochemical staining for p53 protein overexpression was performed on bone marrow biopsies from 9 patients with <z:chebi fb="26" ids="8984">SDS</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>These specimens were compared with biopsies from 71 patients with acquired <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> with variable risk levels for <z:hpo ids='HP_0001909'>leukemia</z:hpo>, including acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (n = 14), <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (n = 46), and various acquired cytopenias (n = 11), as well as 37 control subjects </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: p53 protein overexpression was identified only in patients with <z:chebi fb="26" ids="8984">SDS</z:chebi> and in patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo>; these groups exhibited comparable prevalences of 78% and 72%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>None of the patients with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, acquired cytopenias, or in the control group showed overexpression of p53 protein </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The prevalence of p53 protein overexpression in <z:chebi fb="26" ids="8984">SDS</z:chebi> is significantly different from that in acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and acquired cytopenias, but it is similar to the prevalence in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>We speculate that p53 protein overexpression in this <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndrome may represent an early indicator of significant DNA genetic alteration, which is a crucial step in the process of <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
</text></document>